{"ORPHApacket":[{"ORPHApacketID":"79154","date":"2019-12-05 18:26:29","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"79154","Name":[{"lang":"en","label":"2-aminoadipic 2-oxoadipic aciduria"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_79154","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Disorder of lysine and hydroxylysine metabolism"}],"ORPHA":"289832","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_289832"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"2-aminoadipic 2-oxoadipic aciduria is a rare disorder of lysine and hydroxylysine metabolism characterized by variable clinical presentation including hypotonia, developmental delay, mild to severe intellectual disability, ataxia, epilepsy and behavioral disorders, most commonly attention deficit hyperactivity disorder. Frequently, individuals are completely without clinical phenotype."}],"ExternalReferenceList":[{"count":"1","ExternalReference":[{"Source":"OMIM","Reference":"204750","DisorderMappingRelation":[{"id":"21527","Name":[{"lang":"en","label":"E (exact mapping (the terms and the concepts are equivalent))"}]}]}]}],"AverageAgeOfOnsetList":[{"count":"2","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Childhood"}]},{"Name":[{"lang":"en","label":"Infancy"}]}]}],"SynonymList":[{"count":"1","Synonym":[{"lang":"en","label":"Alpha-aminoadipic aciduria"}]}],"DisorderGeneAssociationList":[{"count":"1","DisorderGeneAssociation":[{"Gene":[{"Name":[{"lang":"en","label":"dehydrogenase E1 and transketolase domain containing 1"}],"Symbol":"DHTKD1","ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"HGNC","Reference":"23537"},{"Source":"OMIM","Reference":"614984"}]}]}],"DisorderGeneAssociationType":[{"OrphaNumber":"317343","Name":[{"lang":"en","label":"Disease-causing germline mutation(s) in"}]}]}]}]}]}